Evidence map›Paper›PMID 34987955›Full record

ArticlePreventive medicine reports2021

Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria.

Adeyemi A Okunowo, Aloy O Ugwu, Jubril O Kuku, Adaiah P Soibi-Harry, Bolanle O Okunowo, Nneoma K Ani-Ugwu, Benedetto O Osunwusi, Muisi A Adenekan

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Adeyemi A OkunowoDepartment of Obstetrics & Gynaecology, College of Medicine, University of Lagos (CMUL) / Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Aloy O UgwuDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Jubril O KukuDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Adaiah P Soibi-HarryDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Bolanle O OkunowoDepartment of Internal Medicine, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Nneoma K Ani-UgwuDepartment of Internal Medicine, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Benedetto O OsunwusiDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Muisi A AdenekanDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Lagos University Teaching Hospital · NGUniversity of Lagos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) vaccination and HPV based cervical screening are scientifically proven ways to prevent and eliminate cervical cancer (CC). Unfortunately, these measures are yet to be widely accepted or utilized. Our study aimed to explore the individual-related factors that predict HPV vaccination and testing, its motivating factors and barriers among urban women in Lagos, Nigeria. This was a descriptive cross-sectional study among 208 consenting women who attended a community health awareness program in Surulere, Lagos, Nigeria, in September 2019. Structured questionnaires were interviewer administered and analysis was done using SPSS version 23. The uptake of HPV vaccination and testing was 29.0% and 3.0% respectively. Being employed [adjusted odds ratio (AOR) = 60.45, CI = 10.64-343.46, P < 0.001] and unmarried (AOR = 33.33, CI = 12.5-100.0, P < 0.001) predicted HPV vaccination uptake while being unmarried was the only predictor of uptake of HPV testing [crude odds ratio (COR) = 7.69, CI = 1.01-100.00, P = 0.039]. Knowing someone with CC (AOR = 21.64, CI = 4.87-96.16, P < 0.001) and being unmarried (AOR = 5.56, CI = 1.45-20.00, P = 0.012) predicted increased willingness to be vaccinated. Being unmarried (AOR = 5.26, CI = 1.89-14.29, P = 0.002) and knowing someone with CC (AOR = 6.41, CI = 2.68-15.33, P < 0.001) predicted willingness to do HPV testing. Recommendation by healthcare provider (HCP), friends/relatives and media were major motivators for HPV vaccination & testing while fear, cost, no recommendation by HCP, inaccessibility & lack of awareness were major barriers. There is need to urgently address these identified factors that affect HPV vaccination and testing in order to improve its acceptability and uptake rate in our environment.

Indexed as

AOR, Adjusted odd ratioBarriersCC, Cervical cancerCervical cancerCI, Confidence intervalCOR, Crude odd ratioHCP, Healthcare providerHDI, Human development indicesHPV, Human papillomavirusHPV testingHPV vaccinationHrHPV, High risk HPVIQR, Interquartile rangeLagos, NigeriaLMIC, Low and middle income countriesLrHPV, Low risk HPVMotivators%, PercentagePredictorsP-value, Probability valueSD, Standard deviationSPSS, Statistical Package for Social Sciences

Identifiers

PMID34987955
PMCPMC8693866
OpenAlexW3214413725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.